AZN Astrazeneca Plc

12,106.00

-20.00 (-0.16%)

19 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Astrazeneca Plc	LSE:AZN	London	Ordinary Share	GB0009895292	ORD SHS $0.25

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-20.00	-0.16%	12,106.00	12,120.00	12,122.00	12,190.00	12,024.00	12,080.00	999,558	16:35:02

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	45.81B	5.96B	3.8415	31.55	187.98B

BOLDER II Study Confirms Therapeutic Potential of SEROQUEL in Bipolar Depression

21/10/2005 8:59am

PR Newswire (US)

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Jul 2019 to Jul 2024

ALDERLEY PARK, England, October 21 /PRNewswire-FirstCall/ -- - For Health Professional Press and Non-UK Journalists Only Newly released top-line results from the BOLDER II (BipOLar DEpRession) study have underlined the potential for SEROQUEL (quetiapine fumarate) in the treatment of patients with major depressive episodes associated with bipolar disorder. In BOLDER II, SEROQUEL 300mg and 600mg doses achieved a statistically significant reduction in levels of bipolar depression compared with placebo (p